Clinical Trials Browser

HER2-positive Advanced Breast Cancer × Vinorelbine × Clear all

NCT05901935 2023-06-13

DP303c in Patients With HER2-positive Advanced Breast Cancer

Phase 3 Not yet recruiting

HER2-positive Advanced Breast Cancer

NCT05856383 2023-05-12

HER2-VIP

HER2-positive Advanced Breast Cancer

NCT04903652 2022-04-07

Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer

Phase 2 Completed

HER2-positive Advanced Breast Cancer